Drug:
Reaction: PNEUMONIA
20250101 - 20251231
No. 901 - 1000
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
901 | 25077606 |
DE |
53 | 2 |
Osteoarthritis, Pulmonary mass, Hidradenitis, Dyspnoea, Abscess, Diarrhoea, Breast abscess, Chronic obstructive pulmonary disease, Pneumonia, Genital abscess, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, |
||||
902 | 25077610 |
US |
82 | 1 |
Pneumonia, Nasopharyngitis, Influenza, |
||||
LENALIDOMIDE, |
||||
903 | 25077727 |
US |
75 | 2 |
Pneumonia, Malaise, Visual impairment, Thirst, Fatigue, Cough, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
904 | 25077747 |
US |
72 | 2 |
Pneumonia, Off label use, |
||||
OSILODROSTAT, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLONAZEPAM, VENLAFAXINE HYDROCHLORIDE, VALBENAZINE, IPRATROPIUM BROMIDE, LAMOTRIGINE, MIDODRINE HYDROCHLORIDE, PANTOPRAZOLE SODIUM, FLUOXETINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, |
||||
905 | 25077784 |
CO |
42 | 2 |
Pneumonia, Arthralgia, Injection site pain, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, ACETAMINOPHEN, ASPIRIN, CAFFEINE, FOLIC ACID, LEFLUNOMIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
906 | 25077941 |
IT |
49 | 1 |
Respiratory failure, Pneumonia, COVID-19, Intentional product use issue, Off label use, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, METHYLPREDNISOLONE, METHYLPREDNISOLONE, TACROLIMUS, TOCILIZUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROXYCHLOROQUINE, |
||||
907 | 25077969 |
CA |
65 | 2 |
Abdominal discomfort, Asthma, Blood pressure increased, Cough, Dyspnoea, Fatigue, Limb injury, Lower respiratory tract congestion, Lower respiratory tract infection, Malaise, Middle insomnia, Nasopharyngitis, Obstructive airways disorder, Pneumonia, Pneumothorax, Productive cough, Pyrexia, Sinus congestion, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBENDAZOLE, MIRTAZAPINE, |
||||
908 | 25078044 |
IL |
80 | 1 |
Aspiration, Dyskinesia, Decreased appetite, Nervousness, Asthenia, Skin bacterial infection, Confusional state, Constipation, Vomiting, Hallucination, visual, On and off phenomenon, Stoma site discharge, Cough, Gastrointestinal motility disorder, Decubitus ulcer, Stoma site haemorrhage, Pneumonia, Stoma site pain, Loss of consciousness, Hypoproteinaemia, Dysphagia, Urinary tract infection, Sepsis, General physical health deterioration, |
||||
909 | 25078056 |
CN |
||
Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Pneumonia, Neutropenia, Sepsis, Febrile neutropenia, Neurotoxicity, Thrombocytopenia, Septic shock, Cytomegalovirus infection reactivation, Tumour lysis syndrome, Neuropathy peripheral, Hypogammaglobulinaemia, Colitis, Pulmonary embolism, Pyelonephritis, Myocarditis, Necrotising fasciitis, Progressive multifocal leukoencephalopathy, Pancytopenia, Cytomegalovirus viraemia, COVID-19, Pyrexia, Infection, Anaemia, Hypotension, Influenza, Injection site erythema, Nausea, Headache, Fatigue, Diarrhoea, Serum ferritin increased, Cytomegalovirus infection, Blood creatinine increased, |
||||
TECLISTAMAB, |
||||
910 | 25078206 |
US |
70 | |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
911 | 25078211 |
CA |
50 | 2 |
Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Asthenia, C-reactive protein abnormal, Condition aggravated, Contraindicated product administered, Contusion, Diarrhoea, Dyspnoea, Discomfort, Fibromyalgia, Frequent bowel movements, Hand deformity, Hepatic enzyme increased, Hypersensitivity, Infection, Insomnia, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus-like syndrome, Malaise, Medication error, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain in extremity, Pancreatitis, Paraesthesia, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rectal haemorrhage, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight fluctuation, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
912 | 25078266 |
US |
73 | 2 |
Pneumonia, Peripheral swelling, |
||||
LENALIDOMIDE, |
||||
913 | 25078353 |
CA |
35 | 2 |
Anxiety, Asthma, Burning sensation, Chest discomfort, Chest pain, Cough, Crying, Dehydration, Depression, Dizziness, Dyspnoea, Emphysema, Feeling cold, Fluid retention, Forced expiratory volume decreased, Hot flush, Hypoventilation, Illness, Injection site pain, Lower respiratory tract infection, Malaise, Influenza, Mental disorder, Nasal congestion, Nasopharyngitis, Nausea, Obstructive airways disorder, Oropharyngeal pain, Pain, Pain in extremity, Peripheral swelling, Pneumonia, Productive cough, Pruritus, Rhinorrhoea, Seasonal allergy, Stress, Suicidal ideation, Syncope, Vomiting, Weight decreased, Weight increased, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, QUETIAPINE FUMARATE, QUETIAPINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
914 | 25078360 |
US |
2 | |
Pneumonia, Crohn^s disease, Blood iron decreased, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, |
||||
915 | 25078362 |
CA |
1 | |
Pneumonia, Malaise, Respiratory tract infection, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, |
||||
916 | 25078443 |
US |
75 | 1 |
Pneumonia, Night sweats, |
||||
DUPILUMAB, |
||||
917 | 25078516 |
BR |
||
Pneumonia, |
||||
918 | 25078747 |
US |
||
Pneumonia, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
919 | 25078759 |
AU |
73 | 1 |
Cerebral haemorrhage, Myocardial infarction, Pneumonia, |
||||
ENOXAPARIN SODIUM, TENECTEPLASE, |
||||
920 | 25078770 |
DE |
||
Differentiation syndrome, Acute kidney injury, Tumour lysis syndrome, Pneumonia, Underdose, |
||||
IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DAPAGLIFLOZIN, PANTOPRAZOLE, RAMIPRIL, ROSUVASTATIN, SPIRONOLACTONE, |
||||
921 | 25078827 |
US |
71 | 2 |
Infection, Pneumonia, Sepsis, Renal failure, Pulmonary thrombosis, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MOMETASONE FUROATE, MOMETASONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RIZATRIPTAN, |
||||
922 | 25078915 |
US |
64 | 1 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
923 | 25079006 |
CA |
36 | 2 |
Pneumonia, |
||||
CLADRIBINE, |
||||
924 | 25079139 |
DE |
58 | 1 |
Death, Pneumonia, General physical health deterioration, |
||||
CARBOPLATIN, PACLITAXEL, PEMBROLIZUMAB, EPINEPHRINE, ADRENALINUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, GRANISETRON, GRANISETRON HYDROCHLORIDE, |
||||
925 | 25079222 |
76 | 1 | |
COVID-19, Pneumonia, |
||||
DEUCRAVACITINIB, |
||||
926 | 25079412 |
JP |
70 | 1 |
Disease progression, Pneumonia, Platelet count decreased, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
927 | 25079431 |
US |
92 | 1 |
Pneumonia, |
||||
ELTROMBOPAG OLAMINE, |
||||
928 | 25079462 |
US |
1 | |
Pneumonia, |
||||
TALAZOPARIB, ENZALUTAMIDE, |
||||
929 | 25079521 |
US |
82 | 2 |
Nausea, Pneumonia, Vomiting, Hypertension, Chest pain, Diarrhoea, |
||||
LENVATINIB, ERGOCALCIFEROL, VANCOMYCIN HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, MEDROXYPROGESTERONE ACETATE, ASCORBIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ESTRADIOL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
930 | 25079620 |
US |
15 | 1 |
Pneumonia, Fatigue, Sleep disorder, Loss of personal independence in daily activities, Pharyngitis streptococcal, Infection, Product dose omission issue, Cystic fibrosis gastrointestinal disease, Flatulence, Abdominal pain upper, Pain, |
||||
TOBRAMYCIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, PANCRELIPASE, PANCRELIPASE, CYPROHEPTADINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, CETIRIZINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DORNASE ALFA, LORATADINE, LORATADINE ORAL, URSODIOL, URSOSIOL, LANSOPRAZOLE, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
931 | 25079656 |
EG |
63 | 2 |
Pneumonia, Dyspnoea, Pyrexia, |
||||
LETROZOLE, LETROZOLE TABLETS, PALBOCICLIB, DENOSUMAB, |
||||
932 | 25079681 |
CA |
75 | |
Atelectasis, Lung hyperinflation, Lung infiltration, Malaise, Pneumonia, Productive cough, |
||||
ACLIDINIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL, MEPOLIZUMAB, MEPOLIZUMAB, MOMETASONE FUROATE, MOMETASONE FUROATE, |
||||
933 | 25079708 |
CA |
69 | 1 |
Pneumonia, |
||||
GOLIMUMAB, |
||||
934 | 25079743 |
CA |
62 | 2 |
Asthenia, Blood pressure decreased, General physical health deterioration, Pneumonia, Vomiting, |
||||
PEMBROLIZUMAB, |
||||
935 | 25079843 |
CL |
73 | 1 |
COVID-19, Pneumonia, |
||||
GOLIMUMAB, |
||||
936 | 25079932 |
CN |
||
Respiratory syncytial virus infection, Cough, Drug ineffective, Pneumonia, |
||||
NIRSEVIMAB, |
||||
937 | 25080006 |
US |
68 | 2 |
Pneumonia, |
||||
REVUMENIB, ACYCLOVIR, ALLOPURINOL, ANASTROZOLE, ANASTROZOLE TABLETS, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ESCITALOPRAM, MAGNESIUM, METOPROLOL TARTRATE, METOPROLOL, PROCHLORPERAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, VORICONAZOLE, |
||||
938 | 25080076 |
CA |
52 | |
Asthma-chronic obstructive pulmonary disease overlap syndrome, Blood bilirubin increased, Bronchiectasis, Cardiac murmur, Cholelithiasis, Chronic obstructive pulmonary disease, Condition aggravated, Gastrooesophageal reflux disease, Hepatic enzyme increased, Hepatotoxicity, Hypomania, Jaundice cholestatic, Lung neoplasm malignant, Nasal polyps, Nausea, Oedema peripheral, Off label use, Pneumonia, Psychotic disorder, Rhinitis allergic, Sarcoidosis, Schizophrenia, Total lung capacity increased, Vomiting, Wheezing, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, QUETIAPINE, BUDESONIDE, PREDNISONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, TIPRANAVIR, TIPRANAVIR, IPRATROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOMETASONE FUROATE, MEPOLIZUMAB, OLANZAPINE, OLANZAPINE, CICLESONIDE, RISPERIDONE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, CARBAMAZEPINE, CARBAMAZEPINE, TIPRANAVIR, DIVALPROEX SODIUM, DIVALPROEX SODIUM, OLANZAPINE, OLANZAPINE PAMOATE, OLANZAPINE, OLANZAPINE PAMOATE, LAMIVUDINE, LAMIVUDINE ORAL, ABACAVIR SULFATE, ABACAVIR, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCIUM CARBONATE, ANTACID, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPINAVIR AND RITONAVIR, LACTULOSE, LITHIUM, LITHIUM BROMATUM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, SERTRALINE, ENFUVIRTIDE, |
||||
939 | 25080088 |
US |
60 | 2 |
Acute respiratory distress syndrome, Pneumonia, Sepsis, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
940 | 25080103 |
US |
73 | 2 |
Swelling, Blood pressure increased, Pneumonia, Fatigue, |
||||
BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUMETANIDE, CARVEDILOL, ERGOCALCIFEROL, GABAPENTIN, EMPAGLIFLOZIN, INSULIN DETEMIR, LISINOPRIL, NIFEDIPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MONTELUKAST, CETIRIZINE HYDROCHLORIDE, |
||||
941 | 25080124 |
CA |
44 | 2 |
Respiratory disorder, Liver disorder, Hepatic cirrhosis, Liver injury, Lupus-like syndrome, Rheumatoid arthritis, Pulmonary fibrosis, Breast cancer stage III, Colitis ulcerative, Crohn^s disease, Deep vein thrombosis postoperative, Porphyria acute, Lower respiratory tract infection, Lupus vulgaris, Pericarditis, Pneumonia, Muscular weakness, Psoriatic arthropathy, Retinitis, Grip strength, Ear infection, Drug tolerance decreased, Delirium, Helicobacter infection, Sleep disorder due to a general medical condition, Arthropathy, Asthenia, Gastrointestinal disorder, General physical health deterioration, Blood cholesterol increased, Grip strength decreased, Hand deformity, Gait disturbance, Foot deformity, Hypercholesterolaemia, Folliculitis, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Fibromyalgia, Irritable bowel syndrome, Joint range of motion decreased, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, RITUXIMAB, RITUXIMAB, |
||||
942 | 25080178 |
CN |
98 | 1 |
Generalised tonic-clonic seizure, Pneumonia, Hypertension, Coronary artery disease, Cerebrovascular insufficiency, Cerebellar haemorrhage, |
||||
943 | 25080205 |
CA |
40 | 2 |
Breast cancer stage II, Psoriatic arthropathy, Type 2 diabetes mellitus, Systemic lupus erythematosus, Hepatitis, Liver injury, Epilepsy, Lower respiratory tract infection, Duodenal ulcer perforation, Pneumonia, Pericarditis, Coeliac disease, Rheumatic fever, Pemphigus, Rheumatoid arthritis, Urticaria, Stomatitis, Helicobacter infection, Wound infection, Vomiting, Pain in extremity, Onychomycosis, Blepharospasm, Synovitis, Peripheral swelling, Depression, Hypertension, Hepatic enzyme increased, Blood cholesterol increased, Adverse reaction, Malaise, Hypersensitivity, Grip strength decreased, Alopecia, Headache, Obesity, Peripheral venous disease, Diarrhoea, Nasopharyngitis, Paraesthesia, Lung disorder, Muscular weakness, Dizziness, Asthenia, Musculoskeletal stiffness, Gastrointestinal disorder, Arthropathy, Hand deformity, Injection site reaction, Inflammation, Blister, General physical health deterioration, Bursitis, Mobility decreased, Liver function test increased, Infusion related reaction, Swelling, Memory impairment, Joint swelling, Live birth, Maternal exposure during pregnancy, Intentional product use issue, Normal newborn, Drug-induced liver injury, Irritable bowel syndrome, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, SECUKINUMAB, |
||||
944 | 25080231 |
CA |
57 | 2 |
Hypertension, Blood pressure increased, Ageusia, Anosmia, Asthma, Oxygen saturation decreased, Productive cough, White coat hypertension, Pneumonia, Malaise, Fatigue, |
||||
TIOTROPIUM BROMIDE, BUDESONIDE, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
945 | 25080274 |
CA |
57 | 1 |
Body temperature decreased, Blood pressure decreased, Blood pressure diastolic decreased, Blood pressure diastolic abnormal, Blood pressure systolic abnormal, Heart rate decreased, Blood pressure systolic increased, Blood pressure fluctuation, Pyrexia, Headache, Pneumonia, Cough, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, PREDNISONE, SULFASALAZINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, DIPHENHYDRAMINE HYDROCHLORIDE, PANTOPRAZOLE, ROSUVASTATIN, METHYLPREDNISOLONE SODIUM SUCCINATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
946 | 25083470 |
54 | 2 | |
Pneumonia, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
947 | 25083471 |
54 | 2 | |
Pneumonia, |
||||
SECUKINUMAB, |
||||
948 | 25083531 |
2 | ||
Pneumonia, Overdose, Weight decreased, Device dislocation, |
||||
SOTATERCEPT-CSRK, TREPROSTINIL, |
||||
949 | 25083800 |
54 | 2 | |
Influenza, Pneumonia, Therapy cessation, |
||||
ADALIMUMAB, |
||||
950 | 25083856 |
65 | 2 | |
Pneumonia, Intentional dose omission, |
||||
ADALIMUMAB, |
||||
951 | 25083902 |
54 | 2 | |
Pneumonia, |
||||
ADALIMUMAB, |
||||
952 | 25083996 |
2 | ||
Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
953 | 25085388 |
46 | 2 | |
COVID-19, Pneumonia, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LISINOPRIL, |
||||
954 | 25071586 |
CA |
2 | |
Pneumonia, Dyspnoea, Cough, Malaise, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
955 | 25071613 |
FR |
||
Haematological malignancy, Cataract, Neutropenia, Pneumonia, Neoplasm, Peripheral sensory neuropathy, Diarrhoea, Upper respiratory tract infection, Infection, |
||||
LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
956 | 25071631 |
US |
||
Bone pain, Fatigue, Anxiety, Pneumonia, Influenza, Renal impairment, |
||||
OSIMERTINIB, HYDROXYZINE, |
||||
957 | 25071640 |
US |
1 | |
Intestinal obstruction, Peripheral swelling, Arthralgia, Infection, Weight decreased, Aspiration, Pneumonia, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, PREDNISONE, |
||||
958 | 25071651 |
JP |
68 | 1 |
Panniculitis, Pneumonia, Liver disorder, Underdose, |
||||
AVACOPAN, AVACOPAN, AVACOPAN, AVACOPAN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
959 | 25071798 |
US |
60 | 2 |
Pneumonia, Rhinovirus infection, Red blood cell count decreased, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISINOPRIL, IXAZOMIB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
960 | 25071807 |
CA |
61 | 2 |
Aphonia, Arthralgia, Body temperature decreased, Cough, Drug hypersensitivity, Ear infection, Hypoventilation, Limb discomfort, Middle ear effusion, Nasopharyngitis, Off label use, Pneumonia, Product use issue, Productive cough, Rash, Road traffic accident, Sinusitis, Tendonitis, Tissue injury, Weight decreased, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, AMOXICILLIN, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, |
||||
961 | 25071908 |
US |
78 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, ESZOPICLONE, FUROSEMIDE, CHOLESTYRAMINE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, LEVOTHYROXINE, ERGOCALCIFEROL, AZELASTINE, ESOMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FEXOFENADINE HYDROCHLORIDE, |
||||
962 | 25071958 |
CA |
80 | 2 |
Pneumonia, Productive cough, Lung disorder, Inappropriate schedule of product administration, |
||||
HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
963 | 25071964 |
CA |
66 | 2 |
Pneumonia, |
||||
GOLIMUMAB, |
||||
964 | 25072301 |
US |
70 | 1 |
Pneumonia, |
||||
965 | 25072315 |
NL |
71 | 1 |
Renal failure, Hospitalisation, Pneumonia, |
||||
CARBIDOPA, LEVODOPA, AND ENTACAPONE, |
||||
966 | 25072330 |
US |
67 | 1 |
Pneumonia, Dyspnoea, Wheezing, Hunger, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, ERGOCALCIFEROL, ALBUTEROL SULFATE, |
||||
967 | 25072354 |
CA |
61 | 2 |
Sinusitis, Asthma, Blood pressure increased, Bronchitis, Contusion, Cough, Dyspnoea, Dyspnoea exertional, Fall, Gait disturbance, Illness, Influenza, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Limb injury, Malaise, Nasopharyngitis, Oxygen saturation decreased, Pain in extremity, Pneumonia, Pulmonary congestion, Rhinitis, Scratch, Seasonal allergy, Speech disorder, Viral infection, Wheezing, Product availability issue, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DESOXIMETASONE, MOXIFLOXACIN HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE OPHTHALMIC, ALBUTEROL SULFATE, ALBUTEROL, GLYCOPYRROLATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, ALBUTEROL SULFATE, |
||||
968 | 25072370 |
US |
91 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
969 | 25072454 |
US |
84 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, ACYCLOVIR, DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
970 | 25072544 |
CN |
2 | |
Pneumonia, White blood cell count decreased, Platelet count decreased, Lymphocyte count decreased, Product use issue, |
||||
RIBOCICLIB, LETROZOLE, |
||||
971 | 25072605 |
US |
38 | 2 |
Blindness, Multiple sclerosis relapse, COVID-19, Pneumonia, Influenza, Skin lesion, Rash, Ill-defined disorder, |
||||
OCRELIZUMAB, |
||||
972 | 25072781 |
CN |
68 | |
Drug eruption, Pneumonia, |
||||
973 | 25072837 |
CA |
65 | 2 |
Angina pectoris, Anaemia, Arthralgia, Arthritis, Balance disorder, Body temperature decreased, Bone pain, Bronchitis, Contusion, Cough, Deafness transitory, Dizziness, Dyspepsia, Ear discomfort, Fatigue, Feeling abnormal, Feeling hot, Frustration tolerance decreased, Gait disturbance, Headache, Hyperhidrosis, Illness, Influenza, Irritability, Joint swelling, Meniere^s disease, Oliguria, Oropharyngeal pain, Pain, Pain in extremity, Paraesthesia, Paraesthesia oral, Peripheral swelling, Pneumonia, Respiratory fume inhalation disorder, Sense of oppression, Sensitivity to weather change, Sinusitis, Sputum discoloured, Tinnitus, Tumour compression, Vertigo, Viral infection, Visual impairment, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE, BUDESONIDE, FUROSEMIDE, DIMENHYDRINATE, ATORVASTATIN CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
974 | 25072852 |
CA |
21 | 2 |
Circumstance or information capable of leading to medication error, Infection, Multiple sclerosis pseudo relapse, Off label use, Pneumonia, |
||||
RITUXIMAB, |
||||
975 | 25072893 |
US |
34 | 2 |
Pneumonia, |
||||
976 | 25072922 |
US |
53 | 1 |
Pneumonia, Dyspnoea, Lung disorder, Gait disturbance, |
||||
DUPILUMAB, |
||||
977 | 25072970 |
US |
69 | 1 |
Pneumonia, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MAGNESIUM HYDROXIDE, PAROXETINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 3350, MELATONIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SERTRALINE HYDROCHLORIDE, ALBUTEROL SULFATE, QUETIAPINE FUMARATE, QUETIAPINE, TETRAHYDROZOLINE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, PREDNISONE, OXYGEN, 0XYGEN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, |
||||
978 | 25073044 |
CA |
76 | 2 |
Pneumonia, Rib fracture, Fatigue, Injection site erythema, Product use issue, |
||||
979 | 25073106 |
JP |
1 | |
Pneumonia, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
980 | 25073196 |
JP |
65 | 2 |
Compression fracture, Pneumonia, |
||||
ROMOSOZUMAB-AQQG, |
||||
981 | 25073260 |
CA |
84 | 2 |
Pneumonia, Treatment noncompliance, |
||||
ADALIMUMAB-RYVK, |
||||
982 | 25073341 |
IT |
68 | 1 |
Leukocytosis, Thrombocytopenia, Condition aggravated, Pyrexia, Pneumonia, Gastric ulcer, |
||||
IMATINIB, DASATINIB, |
||||
983 | 25073386 |
US |
2 | |
Pulmonary fibrosis, Pneumonia, Loss of consciousness, Syncope, Urinary tract infection, Hypotension, Weight decreased, Sleep disorder, Sleep apnoea syndrome, Product dose confusion, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, DESVENLAFAXINE SUCCINATE, LIDOCAINE, METHYLNALTREXONE BROMIDE, NALOXEGOL OXALATE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, POLYETHYLENE GLYCOL 3350, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ROSUVASTATIN CALCIUM, METOLAZONE, GABAPENTIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MORPHINE SULFATE, PRIMIDONE, VARENICLINE TARTRATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOSPORINE, VITAMIN C, OXYGEN, 0XYGEN, |
||||
984 | 25073415 |
US |
71 | 2 |
Fall, Pneumonia, Dyspnoea, COVID-19, |
||||
DUPILUMAB, RIOCIGUAT, |
||||
985 | 25073512 |
CA |
||
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
986 | 25073655 |
US |
2 | |
Pneumonia, Influenza, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, |
||||
987 | 25074048 |
US |
||
Pneumonia, |
||||
ELACESTRANT, |
||||
988 | 25074083 |
CN |
35 | 2 |
Condition aggravated, Pneumonia, |
||||
GLOFITAMAB, |
||||
989 | 25074153 |
61 | 1 | |
Pneumonia, Sepsis, Coronavirus test positive, |
||||
METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
990 | 25074181 |
GB |
5 | 2 |
Pneumonia, Alopecia, Fatigue, Mucosal inflammation, Nausea, Pain, Vomiting, |
||||
DOXORUBICIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, RITUXIMAB, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
991 | 25074199 |
54 | 1 | |
Back pain, Pain, Pneumonia, Unresponsive to stimuli, Cardio-respiratory arrest, Cardiac arrest, Pulse absent, |
||||
LENALIDOMIDE, |
||||
992 | 25074289 |
CA |
||
Abdominal discomfort, Adverse drug reaction, Alopecia, Arthralgia, Anti-cyclic citrullinated peptide antibody positive, Arthritis, Bone erosion, C-reactive protein increased, Condition aggravated, Crohn^s disease, Decreased appetite, Discomfort, Dizziness, Drug hypersensitivity, Drug intolerance, Ear infection, Exostosis, Fatigue, Foot deformity, General physical health deterioration, Glossodynia, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypoaesthesia, Infection, Infusion related reaction, Joint dislocation, Joint stiffness, Joint swelling, Laryngitis, Lupus-like syndrome, Malaise, Mobility decreased, Musculoskeletal stiffness, Nausea, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Pneumonia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatoid arthritis, Rheumatoid factor positive, Synovitis, Systemic lupus erythematosus, Visual impairment, Wound, Exposure during pregnancy, Treatment failure, Contraindicated product administered, Drug ineffective, Therapeutic product effect decreased, Therapeutic product effect incomplete, Incorrect route of product administration, Product use in unapproved indication, Product use issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, AZATHIOPRINE, CALCIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MORPHINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DESOXIMETASONE, DESOXIMETASONE, CALCIUM CARBONATE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, VITAMIN C, VITAMIN C, VITAMIN C, PREDNISONE, BUPROPION HYDROCHLORIDE, BUPROPION, CAFFEINE CITRATE, DICLOFENAC, DICLOFENAC SODIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, SULFASALAZINE, BUPROPION HYDROCHLORIDE, TOFACITINIB, |
||||
993 | 25074300 |
CN |
69 | |
Neutropenic sepsis, Platelet count decreased, Anaemia, Pneumonia, Respiratory failure, Cardiac failure acute, Off label use, Prescribed underdose, |
||||
SELINEXOR, SELINEXOR, SELINEXOR, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, |
||||
994 | 25074365 |
IL |
||
Pneumonia, Rash, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, BENDAMUSTINE HCL, BENDAMUSTINE HCL, ROSUVASTATIN CALCIUM, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, ALLOPURINOL, AMLODIPINE, PEGFILGRASTIM-JMDB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
995 | 25074375 |
CA |
55 | 2 |
Pneumonia, Dyspnoea, Immunodeficiency, Lower respiratory tract infection, Tinnitus, Feeling hot, Agitation, Fatigue, Anxiety, Mobility decreased, Gait disturbance, Joint swelling, Arthralgia, Illness, Therapeutic product effect incomplete, Pharyngitis, Ear infection, Insomnia, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LEFLUNOMIDE, SULFASALAZINE, ERGOCALCIFEROL, NAPROXEN, NAPROXEN SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, LORAZEPAM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TERBINAFINE HYDROCHLORIDE, CIPROFLOXACIN AND DEXAMETHASONE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PREDNISONE, AMOXICILLIN, TRIAZOLAM, CEFUROXIME AXETIL, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LORAZEPAM, AMITRIPTYLINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, PENICILLIN V POTASSIUM, ERGOCALCIFEROL, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, SEMAGLUTIDE, |
||||
996 | 25074566 |
US |
58 | 2 |
Pneumonia, Upper-airway cough syndrome, Throat irritation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
997 | 25074591 |
US |
2 | |
Pneumonia, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
998 | 25074610 |
FR |
||
Haematological malignancy, Neutropenia, Cataract, Pneumonia, Neoplasm, Diarrhoea, Peripheral sensory neuropathy, Upper respiratory tract infection, Infection, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, LENALIDOMIDE, |
||||
999 | 25074626 |
3 | 2 | |
Pneumonia, Diaphragmatic hernia, |
||||
LEVACETYLLEUCINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, URSODIOL, URSOSIOL, |
||||
1000 | 25074639 |
US |
1 | |
Pneumonia, Product dose omission issue, |
||||
TAMSULOSIN HYDROCHLORIDE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE, NEOMYCIN, POLYMYXIN B SULFATES, DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE, NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, GABAPENTIN, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28